Atlas Trials

The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)

Clinical trial NCT03159884 · UNKNOWN

Trial details

NCT number
NCT03159884
Sponsor
Chengdu Kanghong Biotech Co., Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Polypoidal Choroidal Vasculopathy (PCV)
Start date
2015-10-01
Primary completion
2018-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.